Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Qin, SK; Ren, ZG; Meng, ZQ; Chen, ZD; Chai, XL; Xiong, JP; Bai, YX; Yang, L; Zhu, H; Fang, WJ; Lin, XY; Chen, XM; Li, EX; Wang, LN; Chen, CX; Zou, JJ

Qin, SK (corresponding author), Jinling Hosp, Canc Ctr, Nanjing 210002, Jiangsu, Peoples R China.

LANCET ONCOLOGY, 2020; 21 (4): 571

Abstract

Background Blocking the interaction between PD-1 and its ligands is a promising treatment strategy for advanced hepatocellular carcinoma. This study a......

Full Text Link